CDNS vs COLL · P/E 82, rev $5.30B vs P/E 17, rev $181.9M
Cadence Design Systems Inc (CDNS) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Cadence Design Systems Inc (CDNS) is a software - application company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CDNS revenue for 2025-12-31 was $5.30B. Net income was $1.11B. Revenue was up 14.1% from 2024-12-31 to 2025-12-31. CDNS currently screens at market cap $88.27B and trailing P/E 82.0.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
CDNS currently screens at market cap $88.27B and trailing P/E 82.0. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the CDNS and COLL stock pages for the full models.
Not investment advice.